Generator, I guess you must have forgotten the
Post# of 148164
I guess you must have forgotten the reduction in SAEs and improved NEWS2 scores. He telegraphed and then delivered those.
For those forgetting or deliberately obfuscating the science, new2 is clinically more meaningful than the subjective observation of improved cough, myalgia and fever of the primary endpoint.
As discussed last week, the likelihood is high that Cytodyn knows in real time the patient progress, as cD4/CD8 ratios, lymphopenia and cytokine profiles will normalize very quickly in advance of clinical change in LL patients.
It has been posited by physicians with significant trial experience that this would essentially render the blinds of the trial transparent to Cytodyn.
So you may be correct, but I believe Nader. Check back in 216 hours.